ライフサイエンスコーパス: LC-MS

1 LC-MS and immunoassay can detect protein biomarkers.

2 LC-MS is a high-throughput and low-resource technique th

3 LC-MS-based metabolic phenotyping (metabotyping) in urin

4 LC-MS/MS analysis of stem cell secretome revealed the pr

5 LC-MS/MS analysis showed that the levels of adrenic acid

6 LC-MS/MS and proteomics analysis showed the production o

7 LC-MS/MS assay was developed and validated according to

8 LC-MS/MS data of the extracts revealed several secondary

9 LC-MS/MS methodological development was performed using

10 LC-MS/MS methods developed herein provide powerful tools

11 LC-MS/MS quantification of SULTs is highly reliable meas

12 LC-MS/MS showed a variety of phenolic compounds and stil

13 LC-MS/MS was used to evaluate the proposed sample treatm

14 For the 10 LC-MS(2) DDA data sets with > +/-1 Da isolation windows,

15 antification of 100 plasma proteins in >1500 LC-MS runs, the SD range of the retention time during co

16 solid platform for method development in 2D LC-MS protocols in proteomics and peptide retention pred

17 Off-line 2D LC-MS/MS analysis (HILIC-RPLC) of S. cerevisiae whole ce

18 Off-line 2D LC-MS/MS analysis (SCX-RPLC) of S. cerevisiae whole cell

19 A total of 342 LC-MS runs were carried out (two runs were discarded due

20 A LC-MS based quantitative method was developed, validated

21 A LC-MS method involving direct injection of extra-virgin

22 A LC-MS/MS method for synephrine as a biomarker for orange

23 s became the targets in the development of a LC-MS/MS method which underwent a rigorous in-house vali

24 Using a LC-MS method, putative cytochrome P450 metabolites of NM

25 ort, and specific binding assessment using a LC-MS/MS "cold tracer" method, we have identified 8 (PF-

26 Using charge-switch high mass accuracy LC-MS/MS with selected reaction monitoring and product i

27 ta-independent positive mode of acquisition (LC-MS(E)).

28 ovel strategy using affinity extraction (AE) LC-MS to directly measure drug exposure and target engag

29 An LC-MS/MS method using the formate adduct was developed,

30 An LC-MS/MS method was developed, with the limit of detecti

31 1(n-9)/16:0, and has been integrated into an LC-MS(3) workflow.

32 down proteomics analysis that consists of an LC-MS feature-finding algorithm, a database search algor

33 nsporters to root exudation, we performed an LC-MS based non-targeted metabolite profiling of semi-po

34 We illustrate the approach using an LC-MS/MS experiment from an antibody-drug conjugate and

35 Using an LC-MS/MS-based proteomics approach, we identified liver

36 ormed leaf RNA-seq gene expression analysis, LC-MS metabolomics and total phenolics assays in offspri

37 these isoflavonoids, an efficient analytical LC-MS (TOF) technique was used.

38 In this study, using a specific antibody and LC-MS/MS methods, we identified 11,976 Khib sites in 3,0

39 tion, preconcentration on C18 cartridge, and LC-MS quantification.

40 quantification were done using HPLC-DAD and LC-MS/MS.

41 ls were monitored by gel electrophoresis and LC-MS/MS to determine the cleavage site(s) and Asn(347)

42 Ethyl acetate extraction and LC-MS/MS analysis were used for the identification of PR

43 mor-targeting drug analysis such as HPLC and LC-MS.

44 Here, we used specific immunoassays and LC-MS/MS to identify NT-proET-1 (ppET-1[18-50]), Endothe

45 synthesized and characterized by NMR, IR and LC-MS spectroscopic methods.

46 C in human cells using bio-isotopologues and LC-MS/HRMS.

47 though these analytes are amenable to LC and LC-MS detection an additional major benefit of the SERS

48 S extraction with acetonitrile and CG-MS and LC-MS analysis.

49 studies have been performed using GC/MS and LC-MS as analytical platforms, which involve significant

50 C for 60min were identified using LC/MS and LC-MS/MS following monodimensional electrophoresis.

51 Via 2D 600MHz NMR and LC-MS, 16-O-methylcafestol and 16-O-methylkahweol were d

52 ) were isolated and characterised by NMR and LC-MS.

53 ly, we used tandem affinity purification and LC-MS/MS to search for novel proteins that interact with

54 ng, affinity enrichment, high-resolution and LC-MS/MS analysis.

55 Integration of RNA-seq data from TCGA and LC-MS/MS proteomics from WS revealed an upregulation of

56 (TA) contamination using molecular tools and LC-MS/MS.

57 Transcriptomic and LC-MS/MS-based targeted lipidomic analyses were conducte

58 LC-UV-Visible and LC-MS analyses showed that the fast reaction corresponds

59 lectin-magnetic particle conjugate-assisted LC-MS/MS analyses.

60 scribe the first restriction-enzyme-assisted LC-MS/MS sequencing study of the influence of methyl cyt

61 Together with the trypsin digestion based LC-MS/MS analysis using surrogate peptides from differen

62 ication of phospholipids in data acquired by LC-MS and shotgun experiments.

63 n (ADG), rumen fluid metabolomic analysis by LC-MS and multivariate/univariate statistical analysis w

64 Extensive analysis by LC-MS/MS in both positive and negative ion mode was requ

65 rmic acid, ten-fold dilution and analysis by LC-MS/MS using a pH 10 carbonate buffer.

66 The products can be easily analyzed by LC-MS with accurate mass resolution.

67 composition of each extract was analyzed by LC-MS.

68 fractionated by RP-HPLC and then analyzed by LC-MS/MS to identify peptide sequences.

69 ions using microbiological assay (MA) and by LC-MS.

70 of their in vitro antioxidative capacity by LC-MS and oxidation/reduction assay based methods.

71 G1 and G2 determination and confirmation by LC-MS/MS was validated.

72 e structures of hydrazones were confirmed by LC-MS for the first time.

73 ticides) method followed by determination by LC-MS/MS was modified.

74 Antibiotic concentrations were determined by LC-MS/MS measurements.

75 ary androgen measurements were determined by LC-MS/MS.

76 unts of 8-oxodG to be determined directly by LC-MS/MS.

77 h a (13)C-labeled pooled sample, followed by LC-MS analysis, peak pair picking, and peak intensity ra

78 glimepiride from a water sample, followed by LC-MS analysis.

79 involves ribonuclease digestion followed by LC-MS/MS analysis and data interpretation.

80 t on the surface of the objects, followed by LC-MS/MS analysis.

81 o compounds by Mnt, which were identified by LC-MS as cyanidin-3-O-rhamnoside and pelargonidin-3-O-rh

82 Polyphenol compounds were identified by LC-MS-QTof and quantified by UPLC-PDA-FL.

83 A total of 2565 proteins was identified by LC-MS/MS analysis (q-value </= 0.01) that accounted for

84 ographically, and structurally identified by LC-MS/MS.

85 of 45 different proteins were identified by LC-MS/MS.

86 d 11-dehydrocorticosterone) were measured by LC-MS/MS in maternal and cord plasma from 259 Caucasian

87 This suggests that salT measurement by LC-MS/MS holds the promise of complementing existing lab

88 method allows direct kinetic measurements by LC-MS/MS sequencing for oligonucleotides longer than 20

89 e disulfide structure for murine Meteorin by LC-MS analysis of fragments generated by trypsin plus en

90 tudy was to validate an analytical method by LC-MS for simultaneous determination of mycotoxins and f

91 g fumonisin removal capacities (monitored by LC-MS).

92 of the cross-linked product mycocyclosin by LC-MS.

93 used but can potentially be outperformed by LC-MS.

94 ost common approach of analyzing proteins by LC-MS is to digest them into peptides, which can serve a

95 Large molecule quantitation by LC-MS/MS commonly relies on bottom-up or so-called surro

96 ponding metabolites in rat plasma samples by LC-MS/MS.

97 tion of noninvasive sweat collection and CIL LC-MS is a robust analytical tool for sweat metabolomics

98 ge analysis of the milk metabolome using CIL LC-MS should be very useful in future research involving

99 differential chemical isotope labeling (CIL) LC-MS for mapping the metabolome profiles of sweat sampl

100 -performance chemical isotope labeling (CIL) LC-MS method for profiling the carbonyl submetabolome wi

101 We combined LC-MS and (1) H NMR to quantify metabolic changes in Agr

102 bolite profiling of large numbers of complex LC-MS chromatograms remains a challenge.

103 By following bacterial growth and conducting LC-MS-based assays we show here that YdgR facilitates Ca

104 Variation between this and a conventional LC-MS/MS method using authentic standards for calibratio

105 NIS was 9 times faster than the conventional LC-MS method for determining the concentration of APO-F

106 The addition of IMS to conventional LC-MS-based metabolomics and lipidomics workflows has be

107 Design of Experiments (DoE) and a dedicated LC-MS/MS method, the complexity of the different process

108 Conventional data dependent LC-MS is hampered by the low concentration of HCP-derive

109 sion of neurological pathology, we developed LC-MS/MS methods to quantify GlcCer and GlcSph in mouse

110 using targeted metabolomic ((1)H NMR and DI-LC-MS/MS) and proteomic (MALDI-TOF/TOF-MS) platforms.

111 -phase HPLC for purity (99%), peptide digest LC-MS/MS for sequence determination, and circular dichro

112 A stable isotope dilution LC-MS/MS multi-mycotoxin method was developed for 12 dif

113 colorants were analyzed by isotope dilution LC-MS/MS to determine the contamination levels.

114 Direct LC-MS/MS quantification of NA-released sialic acid provi

115 Here, we present the first direct LC-MS/MS study (without isotopic labeling or hydrolysis)

116 ), as established by a combination of direct LC-MS/MS and chiral GC-MS.

117 uber shape regressed on the gene expression, LC-MS, GC-MS and proteomics data sets separately, only g

118 tative proteomics (quadrupole time of flight LC-MS/MS), we analysed the retina of adult longfin wildt

119 s substantially lower with the standard-flow LC-MS (<0.05 minutes) compared with the nanoflow LC-MS m

120 ously into mice and plasma was collected for LC-MS analysis.

121 To date, the main limitations for LC-MS-based untargeted lipidomics reside in the lack of

122 Substituting the salts used for LC-MS with their deuterated form shifts the mass of PCs

123 gations, an optimized, sensitive, label-free LC-MS/MS method for multiplex detection of five allergen

124 Comparative label-free LC-MS/MS profiling of EVs indicated that enhanced minera

125 ECM ligand concentration was derived from LC-MS/MS quantification of the hepatic ECM from mice exp

126 ination and quantitation of proteoforms from LC-MS(1) spectra.

127 The observations have been supported from LC-MS/MS studies that were independently performed.

128 purity of theoretical isolation windows from LC-MS data sets of differing sample types.

129 While orthogonal tandem MS (e.g., LC-MS(2)) experiments from sample extracts can assist in

130 ically coupled with mass spectrometry (e.g., LC-MS).

131 thods (e.g. thin-layer chromatography, HPLC, LC-MS/MS).

132 gree of confidence in the use of a single IA-LC-MS/MS quantitation assay.

133 Currently, there is interest in implementing LC-MS in biopharmaceutical HCP profiling alongside conve

134 Clean extracts are essential in LC-MS/MS, since the matrix effect can interfere in the a

135 ked bed, pepsin IMER column commonly used in LC-MS based protein analyses.

136 A simple, sensitive and inexpensive LC-MS/MS method was developed and validated for for the

137 igh abundance proteins and labeled for iTRAQ LC-MS/MS separately.

138 esults show that (12)C-/(13)C-DnsHz labeling LC-MS is a useful tool for profiling the carbonyl submet

139 r gemcitabine treatment using iTRAQ labeling LC-MS/MS, because it was featured with the advantages of

140 are only experimentally feasible with lower LC-MS/MS detection limits and/or concentrated extracts o

141 ost and preparation time, of peptide mapping LC-MS workflows in protein analytical research, we here

142 Compared to microflow LC-MS, the nanoflow system provided much improved metabo

143 subsequent liquid chromatography tandem MS (LC-MS/MS) analysis of hydrogel extracts.

144 -high resolution MS (LC-HRMS), LC-tandem MS (LC-MS/MS) and nuclear magnetic resonance (NMR) spectrosc

145 of top-down liquid chromatography-tandem MS (LC-MS/MS) data sets is rapidly increasing on account of

146 nalysis and liquid chromatography-tandem MS (LC-MS/MS), we selected three high abundance peptide mark

147 Molar sums of PFASs obtained by GC-MS, LC-MS/MS, and precursors were compared to total fluorine

148 ion broth, followed by rapid, multiattribute LC-MS analysis.

149 specific peptides was monitored by multiplex LC-MS/MS through the parallel reaction monitoring mode o

150 The multiplexed LC-MS/MS assay using selected reaction monitoring (SRM)

151 ants, immunoprecipitation combined with Nano LC-MS/MS mass spectrometry was conducted on the erythrol

152 ro simulation digestion and analyzed by nano-LC-MS/MS.

153 S run time to almost a third of the nanoflow LC-MS approach.

154 S (<0.05 minutes) compared with the nanoflow LC-MS method (0.26-0.44 minutes).

155 A new LC-MS/MS method was developed and validated, allowing se

156 This paper presents a novel LC-MS data annotation method, termed Biologically Consis

157 Here, we describe a novel LC-MS-based method that quantitatively assesses both (14

158 Unsupervised chemometric analysis of LC-MS/MS data, however, revealed clear separation of HTS

159 stical modeling, and model-based analysis of LC-MS/MS data.

160 The multiplexing capability of LC-MS combined with a standard-flow method increases thr

161 Comparison of LC-MS with MA revealed that MA inaccurately estimates fo

162 The technological development of LC-MS instrumentation has led to significant improvement

163 r (RAMM), to assist in the interpretation of LC-MS/MS data.

164 Most software suites allow preprocessing of LC-MS chromatograms to obtain comprehensive information

165 To systematically score the quality of LC-MS/MS data, we used the correlation between signals i

166 g approach to calculate the selectivities of LC-MS acquisition modes taking mass accuracy, sample mat

167 mi-automated processing and visualization of LC-MS/MS-based lipidomics data.

168 extracts was needed and the method, based on LC-MS/MS quantitation, proved matrix-independent.

169 upplementation were analyzed by GC-MS and/or LC-MS over time courses during nitrogen starvation to ad

170 s, conventional analyses such as HPLC-DAD or LC-MS lose valuable information on metabolite localizati

171 of 4573 +/- 505 (n = 108) pairs detected per LC-MS run.

172 tabolites measured by ultra-high performance LC-MS/GC-MS and retinol concentration (from HPLC) using

173 PGC LC-MS of complex mixtures demonstrated that compounds el

174 the use of a porous graphitized carbon (PGC) LC-MS method with effective separation and sensitivity t

175 and analyzed with untargeted reversed phase LC-MS showed that the highest number of metabolite featu

176 al component analysis (PCA) of the processed LC-MS data demonstrated the varying chemical composition

177 RNA-sequencing and quantitative proteomics (LC-MS/MS) to elucidate the role of this chaperone in the

178 try (GC/MS) system, as an add-on for a rapid LC-MS conversion.

179 hat allow for pre- and postprocessing of raw LC-MS data.

180 More recently, LC-MS for residual HCP characterization has emerged as a

181 A rapid and reliable LC-MS method for determining the triterpenic acids and d

182 In addition, high resolution LC-MS/MS analysis revealed the presence of a novel serie

183 lication of MCR-ENALS to the high-resolution LC-MS data.

184 quantified in an untargeted high-resolution LC-MS experiment, resulting in 18,556 quantitative mass-

185 ion strategy for analysis of high-resolution LC-MS is also demonstrated.

186 This highly sensitive and robust LC-MS/MS technique was applied successfully for the dete

187 e development of a rapid, simple, and robust LC-MS/MS-based enzyme assay using dried blood spots (DBS

188 The present strategy, HIFU-TiO2-SCX-LC-MS/MS, is the fastest analytical method reported to d

189 A simple, rapid, selective and sensitive LC-MS/MS method was developed and validated for the dete

190 as a NAFLD biomarker in serum using a single LC-MS acquisition.

191 ines the biomarker concentration in a single LC-MS acquisition.

192 e cleanup and analyte enrichment (online-SPE-LC-MS/MS).

193 Tissue-specific LC-MS/MS analysis revealed the presence of secologanin a

194 uid chromatography/tandem mass spectrometry (LC-MS(2)).

195 chromatography-multistage mass spectrometry (LC-MS(n)) is the most common method for biomonitoring DN

196 by liquid chromatography-mass spectrometry (LC-MS) after glycan release.

197 rom liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-MS (GC-MS) data relative t

198 ion liquid chromatography-mass spectrometry (LC-MS) and tandem mass spectrometry (MS/MS) to quantify

199 in liquid chromatography-mass spectrometry (LC-MS) based untargeted metabolomics.

200 of liquid chromatography-mass spectrometry (LC-MS) data requires the differentiation between a small

201 can liquid chromatography-mass spectrometry (LC-MS) data sets and tailors peak detection for each met

202 on liquid chromatography-mass spectrometry (LC-MS) data, with lung cancer cases at the time of BAL c

203 by liquid chromatography-mass spectrometry (LC-MS) for biomarker determination using ProGastrin Rele

204 chromatography coupled to mass spectrometry (LC-MS) for the analysis of biomolecules.

205 on liquid chromatography-mass spectrometry (LC-MS) for the measurement of p-XSC in plasma.

206 vel liquid chromatography-mass spectrometry (LC-MS) interfacing concept is presented and discussed.

207 cal liquid chromatography-mass spectrometry (LC-MS) metabolomics workflow, such as metabolite extract

208 f a liquid chromatography-mass spectrometry (LC-MS) method to separate and quantify R- and S-9-PAHSA,

209 Liquid chromatography-mass spectrometry (LC-MS) methods are most often used for untargeted metabo

210 cal liquid chromatography-mass spectrometry (LC-MS) peaks, enabling real-time browsing of large data

211 by liquid chromatography-mass spectrometry (LC-MS) profiling.

212 gun liquid chromatography-mass spectrometry (LC-MS) proteomic and metabonomic profiling approaches on

213 and liquid chromatography mass spectrometry (LC-MS) with a focus of using dansylation labeling to tar

214 ing liquid chromatography-mass spectrometry (LC-MS), capillary electrophoresis (CE), or gas chromatog

215 rm: liquid chromatography-mass spectrometry (LC-MS), gas chromatography-mass spectrometry (GC-MS), nu

216 ing liquid chromatography mass spectrometry (LC-MS), then the molecular features for respective compo

217 the liquid chromatography-mass spectrometry (LC-MS)-based detection of BPDE-N(2)-dG in BaP-treated ro

218 ted liquid-chromatography-mass spectrometry (LC-MS)-based metabolomics analysis of human biospecimens

219 ng, liquid chromatography-mass spectrometry (LC-MS)-based metabolomics, quality control (QC), molecul

220 ing liquid chromatography-mass spectrometry (LC-MS)-based proteomics, peptidomics, and metabolomics.

221 and liquid chromatography-mass spectrometry (LC-MS).

222 uid chromatography tandem mass spectrometry (LC-MS).

223 ine liquid chromatography-mass spectrometry (LC-MS).

224 or liquid chromatography-mass spectrometry (LC-MS); and MS-FINDER 2.0, a structure-elucidation progr

225 uid Chromatography Tandem Mass Spectrometry (LC-MS/MS) analysis of affinity chromatography purified a

226 for the sequential tandem mass spectrometry (LC-MS/MS) analysis of non-polar lipids, polar metabolite

227 uid chromatography tandem mass spectrometry (LC-MS/MS) analysis of the tissues, and quantified relati

228 uid chromatography-tandem mass spectrometry (LC-MS/MS) and constructed a relative release index based

229 uid chromatography-tandem mass spectrometry (LC-MS/MS) and their total amount corresponded to 33% of

230 ography coupled to tandem mass spectrometry (LC-MS/MS) for quantitative measurements of primary metab

231 uid chromatography tandem mass spectrometry (LC-MS/MS) has proven to be a powerful analytical tool fo

232 uid chromatography-tandem mass spectrometry (LC-MS/MS) is an important analytical method for characte

233 uid chromatography-tandem mass spectrometry (LC-MS/MS) is poised to provide a deep understanding of r

234 ography coupled to tandem mass spectrometry (LC-MS/MS) is the main method for high-throughput identif

235 uid chromatography/tandem-mass spectrometry (LC-MS/MS) method to directly assess pyruvate cycling rel

236 uid chromatography-tandem mass spectrometry (LC-MS/MS) method was used with the aim of quantifying mo

237 uid chromatography-tandem mass spectrometry (LC-MS/MS) peptide sequencing (multiplex substrate profil

238 uid chromatography-tandem mass spectrometry (LC-MS/MS) screening for 23 classes of PFASs, followed by

239 sed liquid chromatography-mass spectrometry (LC-MS/MS) to investigate the murine lipidome during norm

240 uid chromatography tandem mass spectrometry (LC-MS/MS) using a high-resolution mass spectrometer.

241 uid chromatography tandem mass spectrometry (LC-MS/MS) was used for collection, identification, and q

242 uid chromatography-tandem mass spectrometry (LC-MS/MS) were developed and validated to quantify the a

243 and liquid chromatography mass spectrometry (LC-MS/MS) were employed for the first time to identify m

244 uid chromatography-tandem mass spectrometry (LC-MS/MS) were used to quantify volatile and ionic PFASs

245 uid chromatography-tandem mass spectrometry (LC-MS/MS) within the hydrolysates.

246 uid chromatography-tandem mass spectrometry (LC-MS/MS), (13)C6-metabolites were radiocalibrated by th

247 uid chromatography tandem mass spectrometry (LC-MS/MS), a widely used method for comparative 'omics a

248 uid chromatography tandem mass spectrometry (LC-MS/MS), qualitative/quantitative structure activity r

249 uid chromatography-tandem mass spectrometry (LC-MS/MS)-based proteomics revealed elongation factor 1

250 uid chromatography-tandem mass spectrometry (LC-MS/MS).

251 uid chromatography-tandem mass spectrometry (LC-MS/MS).

252 uid chromatography-tandem mass spectrometry (LC-MS/MS).

253 uid chromatography-tandem mass spectrometry (LC-MS/MS).

254 uid chromatography tandem mass spectrometry (LC-MS/MS).

255 uid chromatography/tandem mass spectrometry (LC-MS/MS).

256 chromatography and tandem mass spectrometry (LC-MS/MS).

257 uid chromatography-tandem mass spectrometry (LC-MS/MS).

258 uid chromatography tandem mass-spectrometry (LC-MS/MS) have led to the identification of metabolite b

259 resis(2D-DIGE) followed by mass spectrometry(LC-MS/MS).

260 coumarins was further verified by a targeted LC-MS based coumarin profiling method.

261 Samples were reanalyzed using targeted LC-MS/MS to confirm the accuracy of each acquisition met

262 The LC-MS estimation of red-ripe fruits detected three folat

263 The LC-MS method was optimized for a broad range of small or

264 The LC-MS(2) analysis revealed a wide range of phenolics, hi

265 The LC-MS/MS method was specific for all five tested SULTs,

266 e results were highly comparable between the LC-MS platforms tested.

267 Furthermore, the LC-MS/MS and quantitative real-time-PCR analysis followe

268 and optimization of peak integration in the LC-MS/MS data after acquisition.

269 r a simple dilution) of the samples into the LC-MS system was also tested, in an attempt to proffer a

270 e mass recordings (1.5 ppm tolerance) of the LC-MS data set and filtering procedures.

271 ,080 putatively monoisotopic features of the LC-MS data set.

272 We have reduced the LC-MS run time to almost a third of the nanoflow LC-MS a

273 ge, and high-throughput in comparison to the LC-MS based approach.

274 al activity of the sample extracts using the LC-MS data indicated that high activity in the extracts,

275 up a rapid and accurate method, by using the LC-MS-IT-TOF technology, to detect and quantify CBD, CBD

276 n unsweetened natural yogurt) prior to their LC-MS analysis.

277 of matrix effects, even for high-throughput LC-MS methods.

278 d using a simple, isocratic, high-throughput LC-MS workflow.

279 ncreased approximately threefold compared to LC-MS alone due to a combination of the reduction of che

280 bility spectrometry (TWIMS) into traditional LC-MS-based metabolomic and lipidomic workflows.

281 AIF had lower selectivities than traditional LC-MS/MS, produced one false positive and did not detect

282 A selectivities were better than traditional LC-MS/MS, showed no bias toward the most intense signals

283 An untargeted LC-MS/MS platform was implemented for monitoring variati

284 tively supports both targeted and untargeted LC-MS lipidomics, implementing data acquisition, user-fr

285 osition on metabolome coverage in untargeted LC-MS metabolomics.

286 Therefore we developed a selective bottom-up LC-MS methodology for quantitative gelatin species deter

287 Using LC-MS, we demonstrate that 6c is CNS-permeant.

288 Using LC-MS, we determined that each germinating alfalfa seed

289 Using LC-MS, we discovered low endogenous levels of tyrosine n

290 nvestigated during 2012/13 and 2013/14 using LC-MS/MS.

291 via (Stevia rebaudiana Bertoni) leaves using LC-MS in high resolution mode with a quadrupole-time of

292 The metabolite levels were measured using LC-MS following treatment with colistin (2 mg/L) or dori

293 a complex mixtures of tryptic peptides using LC-MS/MS, showing not only that AI-ETD can nearly double

294 een observed directly in human samples using LC-MS techniques, even though sophisticated methodologie

295 The validated LC-MS/MS method is suitable for further toxicodynamic an

296 -ligand complex has been explored by UV-Vis, LC-MS, FIR, Fluorescence titration, Job's plot method an

297 Q Orbitrap MS in a simple and efficient way; LC-MS of a trypsin-digested bovine serum albumin (BSA) s

298 btained showed an excellent correlation with LC-MS/MS analysis.

299 ed interface, be directly interfaceable with LC-MS.

300 ion of the in vivo and chemical studies with LC-MS characterization and assay development also provid